AnalystsGraig Suvannavejh
Graig Suvannavejh's Stock Forecasts

Analyst Ranking
Top 9%
#427 out of 5116 analysts
Average Return
+11.85%
Win Rate
58%81 out of 140
Risk vs Reward
Poor
Good

Graig Suvannavejh's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Amylyx Pharmaceuticals IncAMLX
+332.95%$3.46$14.98
2025-04-06 -
2025-11-28
Buy
Insmed IncINSM
+266.11%$20.36$74.54
2023-07-25 -
2024-07-26
Strong Buy
Terns Pharmaceuticals IncTERN
+245.33%$8.14$28.11
2025-10-21 -
2025-11-28
Buy
Amylyx Pharmaceuticals IncAMLX
+244.37%$4.35$14.98
2025-05-13 -
2025-11-28
Buy
Insmed IncINSM
+197.15%$23.88$70.96
2023-10-26 -
2024-10-25
Strong Buy

Graig Suvannavejh Analyst Color

Get additional color on Graig Suvannavejh's coverage of popular stocks

Graig Suvannavejh's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Belite Bio IncBLTE
1Hold$105.00-23.60%Initiates Coverage On
9 days ago
Tarsus Pharmaceuticals IncTARS
1Buy$100.00+25.06%Initiates Coverage On
9 days ago
Immatics NvIMTX
4Buy$23.00+115.15%Maintains
10 days ago
Halozyme Therapeutics IncHALO
5Hold$56.00-21.57%Maintains
11 days ago
Terns Pharmaceuticals IncTERN
8Buy$33.00+17.40%Maintains
16 days ago
Ideaya Biosciences IncIDYA
3Buy$46.00+29.14%Maintains
18 days ago
Harmony Biosciences Holdings IncHRMY
20Buy$39.00+10.51%Maintains
23 days ago
Axsome Therapeutics IncAXSM
22Buy$202.00+33.33%Maintains
23 days ago
Apellis Pharmaceuticals IncAPLS
11Hold$19.00-10.80%Maintains
a month ago
Bioxcel Therapeutics IncBTAI
9Hold$4.00+77.78%Maintains
3 months ago
Kala Bio IncKALA
1Buy$30.00+3,005.59%Initiates Coverage On
3 months ago
Insmed IncINSM
8Buy$165.00-20.59%Maintains
4 months ago
Alector IncALEC
5Buy$3.50+163.16%Upgrades
4 months ago
Neumora Therapeutics IncNMRA
2Buy$5.00+123.21%Maintains
4 months ago
Adverum Biotechnologies IncADVM
5Buy$12.00+191.26%Maintains
5 months ago
Adaptimmune Therapeutics PLCADAPY
3Hold$0.50+825.93%Downgrades
5 months ago
Immuneering CorpIMRX
2Buy$10.00+30.55%Maintains
5 months ago
Corvus Pharmaceuticals IncCRVS
3Buy$11.00+19.96%Maintains
6 months ago
Eyepoint Pharmaceuticals IncEYPT
5Buy$26.00+75.32%Maintains
6 months ago
Amylyx Pharmaceuticals IncAMLX
7Buy$8.00-46.60%Maintains
7 months ago
Immunocore Holdings PLCIMCR
8Hold$33.00-16.46%Maintains
8 months ago
Intra Cellular Therapies IncITCI
11Hold$132.00+0.10%Downgrades
9 months ago
Autolus Therapeutics PLCAUTL
1Strong Buy$7.60N/AUpgrades
a year ago
Corbus Pharmaceuticals Holdings IncCRBP
1Buy$74.00N/AReiterates
a year ago
Athira Pharma IncATHA
3Hold$5.00N/ADowngrades
a year ago
Cerevel Therapeutics Holdings IncCERE
9Hold$45.00N/AMaintains
2 years ago
Karuna Therapeutics IncKRTX
3Strong Buy$258.00N/AMaintains
2 years ago
Rain Oncology IncRAIN2
5Hold$1.00N/ADowngrades
2 years ago
Vigil Neuroscience IncVIGL
1Strong Buy$15.00N/AInitiates Coverage On
3 years ago
Rhythm Pharmaceuticals IncRYTM
3Strong Buy$35.00N/AMaintains
3 years ago
Kodiak Sciences IncKOD
4Hold$8.00N/AMaintains
3 years ago
Tg Therapeutics IncTGTX
2Strong Sell$26.00N/ADowngrades
4 years ago
Disc Medicine IncIRON
2Strong Buy$18.00N/AMaintains
4 years ago
Valneva SeVALN
1Strong Buy$34.00N/AInitiates Coverage On
4 years ago
Design Therapeutics IncDSGN
1Hold$28.00N/AInitiates Coverage On
5 years ago
Edgewise Therapeutics IncEWTX
1Hold$31.00N/AInitiates Coverage On
5 years ago
Vor Biopharma IncVOR
1Strong Sell$380.00N/AInitiates Coverage On
5 years ago
Innate Pharma SaIPHA
1Hold$4.75N/AInitiates Coverage On
5 years ago
Arcutis Biotherapeutics IncARQT
2Strong Buy$36.00N/AUpgrades
5 years ago
Cytokinetics IncCYTK
1Hold$16.00N/AInitiates Coverage On
5 years ago
Galapagos NvGLPG
1Strong SellN/AN/ADowngrades
5 years ago
Prelude Therapeutics IncPRLD
1Hold$37.00N/AInitiates Coverage On
5 years ago
Jazz Pharmaceuticals PLCJAZZ
1Strong Sell$128.00N/ADowngrades
5 years ago
Tricida IncTCDAQ
1Hold$10.00N/ADowngrades
5 years ago
Flexion Therapeutics IncFLXN1
1Hold$15.00N/AInitiates Coverage On
5 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$29.00N/AInitiates Coverage On
6 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$35.00N/AInitiates Coverage On
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.